Home

Caplin Point Laboratories Ltd PE Ratio

Image

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT

PE

36

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Caplin Point Laboratories Ltd is 36 as of 15 Jan 10:23 AM .
  • The P/E Ratio of Caplin Point Laboratories Ltd changed from 9.9 on March 2020 to 21.9 on March 2024 . This represents a CAGR of 17.21% over 5 years.
  • The Latest Trading Price of Caplin Point Laboratories Ltd is ₹ 2263 as of 15 Jan 10:16 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Caplin Point Laboratories Ltd

No data available

Company Fundamentals for Caplin Point Laboratories Ltd

Image

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT

Share Price

₹ 2263.7

-70.35 (-3.01%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Caplin Point Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Caplin Point Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20252334.05
13 Jan 20252260.4
10 Jan 20252373.75
09 Jan 20252478.35
08 Jan 20252580.05
07 Jan 20252553.2
06 Jan 20252510
03 Jan 20252536.5
02 Jan 20252560.05
01 Jan 20252508.55

SWOT Analysis Of Caplin Point Laboratories Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Caplin Point Laboratories Ltd

Asset Value vs Market Value of Caplin Point Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Caplin Point Laboratories Ltd17741
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Caplin Point Laboratories Ltd Explained

``

17741

Market cap

493

Earnings

36.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Caplin Point Laboratories Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Caplin Point Laboratories Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Caplin Point Laboratories Ltd

No data available

* All values are in %

About Caplin Point Laboratories Ltd

  • Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16th, 1990.
  • The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
  • Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
  • It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
  • In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.

Caplin Point Laboratories Ltd News Hub

Volumes spurt at Caplin Point Laboratories Ltd counter

Hindustan Zinc Ltd, Godfrey Phillips India Ltd, Angel One Ltd, Triveni Engineering and Industries Lt

Read more

2024-08-19 00:00:00

Caplin Point Laboratories Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, Godfrey Phillips India Ltd, Gravita India Ltd and Poly Medicure Ltd are am

Read more

2024-08-19 00:00:00

Benchmarks trades with small gains; media shares in demand

The domestic equity benchmarks traded with decent gains in morning trade. The Nifty traded above the

Read more

2024-08-19 00:00:00

Caplin Point hits life high after Chennai unit clears Brazilian Agency's inspection

ANVISA conducted an inspection of Caplin Steriles' injectable and ophthalmic manufacturing facility

Read more

2024-08-19 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Caplin Point Laboratories Ltd

What is the current PE Ratio of Caplin Point Laboratories Ltd?

The Current PE Ratio of Caplin Point Laboratories Ltd is 35.95 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Caplin Point Laboratories Ltd last year?

The PE Ratio of Caplin Point Laboratories Ltd was 12.04 last year, now the PE ratio is 35.95, showing a year-on-year growth of 198.6%.

What does the PE Ratio of Caplin Point Laboratories Ltd indicate about its stock?

The PE Ratio of Caplin Point Laboratories Ltd is 35.95. This ratio indicates that investors are willing to pay 35.95 times the earnings per share for each share of Caplin Point Laboratories Ltd.

What is the PE Ratio Growth of Caplin Point Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Caplin Point Laboratories Ltd grew by 198.6% whereas, the EPS ratio grew by 5.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions